Marksans Pharma

Price chart

Previous close

₹303.75

Open

₹305.30

Day high

₹313.50

Day low

₹305.20

Listed on NSE since 21 January 2002.

Market value

₹13,767 Cr

P/E (trailing)

24.60

EPS (trailing)

₹12.35

Price to book

4.13

Dividend yield

0.30%

Return on equity

18.6%

Debt to equity

0.14

Profit margin

16.5%

Beta

1.11

Volume today

5.59 L

Average volume

33.52 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Marksans Pharma’s results filed with NSE, consolidated (the whole group). Net profit is the share of Marksans Pharma’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Marksans Pharma’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Industry

Drug Manufacturers - General

Based in

Mumbai

Employees

1,685

Company website · Profile: Yahoo Finance

No headlines name Marksans Pharma in the last day or two.

• Dividend - Re 0.90 Per Share

  Dividend · ex-date 20 August 2026

• Dividend - Re 0.80 Per Share

  Dividend · ex-date 1 August 2025

• Dividend - Rs 0.60 Per Share

  Dividend · ex-date 17 September 2024

• Dividend - Re 0.50 Per Share

  Dividend · ex-date 7 June 2023

• Annual General Meeting/Dividend - Rs 0.25 Per Share

  Dividend · ex-date 19 August 2022

• Annual General Meeting/Dividend - Rs 0.25 Per Share

  Dividend · ex-date 15 September 2021

• Extra-Ordinary General Meeting

  Action · ex-date 1 July 2021 · record date 2 July 2021

• Annual General Meeting/Dividend - Rs 0.10 Per Share

  Dividend · ex-date 22 September 2020

Source: NSE. Latest first, 8 of 20.